共 76 条
[1]
Albanesi C, 1999, J IMMUNOL, V162, P494
[2]
Albanesi Cristina, 2005, Current Drug Targets - Inflammation and Allergy, V4, P329, DOI 10.2174/1568010054022033
[3]
Asadullah Khusru, 2004, Current Drug Targets - Inflammation and Allergy, V3, P185, DOI 10.2174/1568010043343886
[4]
The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients
[J].
JOURNAL OF INVESTIGATIVE DERMATOLOGY,
1999, 113 (05)
:752-759
[6]
KINETICS AND REGULATION OF HUMAN KERATINOCYTE STEM-CELL GROWTH IN SHORT-TERM PRIMARY EX-VIVO CULTURE - COOPERATIVE GROWTH-FACTORS FROM PSORIATIC LESIONAL T-LYMPHOCYTES STIMULATE PROLIFERATION AMONG PSORIATIC UNINVOLVED, BUT NOT NORMAL, STEM KERATINOCYTES
[J].
JOURNAL OF CLINICAL INVESTIGATION,
1995, 95 (01)
:317-327
[9]
Psoriasis: dysregulation of innate immunity
[J].
BRITISH JOURNAL OF DERMATOLOGY,
2005, 152 (06)
:1098-1107